KIA
ONC

Knollwood Investment Advisory’s BeOne Medicines Ltd ONC Stock Holding History

Knollwood Investment Advisory’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,111
Closed -$330K – 315
2026
Q1 		$330K Hold
1,111
– – 0.03% 256
2025
Q4 		$338K Hold
1,111
– – 0.03% 269
2025
Q3 		$379K Sell
1,111
-39
-3% -$11.8K 0.03% 285
2025
Q2 		$278K Hold
1,150
– – 0.03% 316
2025
Q1 		$313K Hold
1,150
– – 0.03% 303
2024
Q4 		$212K Hold
1,150
– – 0.02% 345
2024
Q3 		$258K Buy
+1,150
New +$207K 0.03% 332

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Knollwood Investment Advisory's ONC Position: Q2 2026 in Review

Knollwood Investment Advisory sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 1,111 shares — an estimated $330K sold.

Knollwood Investment Advisory first reported a position in ONC in Q3 2024 and held it in 7 quarters. The position peaked at $379K in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Knollwood Investment Advisory reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Knollwood Investment Advisory sold 1,111 BeOne Medicines Ltd shares in Q2 2026, an estimated $330K.
  • Knollwood Investment Advisory first reported a position in BeOne Medicines Ltd in Q3 2024 and held it in 7 quarters.
  • Knollwood Investment Advisory's BeOne Medicines Ltd position peaked at $379K in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Knollwood Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.